Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment
出版年份 2023 全文链接
标题
Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment
作者
关键词
-
出版物
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 29, Issue 40, Pages 5566-5581
出版商
Baishideng Publishing Group Inc.
发表日期
2023-10-27
DOI
10.3748/wjg.v29.i40.5566
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Challenges and exploration for immunotherapies targeting cold colorectal cancer
- (2023) Dan-Dan Li et al. World Journal of Gastrointestinal Oncology
- Genetic analysis of Japanese patients with small bowel adenocarcinoma using next-generation sequencing
- (2022) Atsushi Tatsuguchi et al. BMC CANCER
- Colorectal Cancer-Infiltrating Regulatory T Cells: Functional Heterogeneity, Metabolic Adaptation, and Therapeutic Targeting
- (2022) Sonia Aristin Revilla et al. Frontiers in Immunology
- Risk factors for small intestinal adenocarcinomas that are common in the proximal small intestine
- (2022) Shunji Fujimori et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Efficacy of Pembrolizumab Monotherapy for Advanced Gastric/Gastroesophageal Junction Cancer with Programmed Death Ligand 1 Combined Positive Score {greater than or equal to}10
- (2021) Zev A. Wainberg et al. CLINICAL CANCER RESEARCH
- ZEBRA: A Multicenter Phase II Study of Pembrolizumab in Patients with Advanced Small-Bowel Adenocarcinoma
- (2021) Katrina S. Pedersen et al. CLINICAL CANCER RESEARCH
- DNA methylation-based signature of CD8+ tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancer
- (2021) Qi Zou et al. Journal for ImmunoTherapy of Cancer
- Prognostic value of immune factors in the tumor microenvironment of patients with pancreatic ductal adenocarcinoma
- (2021) Sachie Kiryu et al. BMC CANCER
- Correlation between schistosomiasis and CD8+ T cell and stromal PD-L1 as well as the different prognostic role of CD8+ T cell and PD-L1 in schistosomal-associated colorectal cancer and non-schistosomal-associated colorectal cancer
- (2021) Weixia Wang et al. World Journal of Surgical Oncology
- Prognostic value of the density of tumor‑infiltrating lymphocytes in colorectal cancer liver metastases
- (2021) En Wang et al. Oncology Letters
- Prognostic Value of Immune Environment Analysis in Small Bowel Adenocarcinomas with Verified Mutational Landscape and Predisposing Conditions
- (2020) Erkki-Ville Wirta et al. Cancers
- FoxP3+ T regulatory cells in cancer: Prognostic biomarkers and therapeutic targets
- (2020) Reem Saleh et al. CANCER LETTERS
- Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer
- (2020) Kohei Shitara et al. JAMA Oncology
- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology
- (2019) Al B. Benson et al. Journal of the National Comprehensive Cancer Network
- Prognostic implications of immune classification in a multicentre cohort of patients with small intestinal adenocarcinoma
- (2019) Byeong-Joo Noh et al. PATHOLOGY
- Clinical Utility of the Combined Positive Score for Programmed Death Ligand-1 Expression and the Approval of Pembrolizumab for Treatment of Gastric Cancer
- (2018) Karina Kulangara et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer
- (2018) Charles S. Fuchs et al. JAMA Oncology
- FDA Approval Summary: Pembrolizumab for Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Expressing PD‐L1
- (2018) Lola Fashoyin‐Aje et al. ONCOLOGIST
- Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
- (2018) T A Chan et al. ANNALS OF ONCOLOGY
- Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study
- (2017) Michael J Overman et al. LANCET ONCOLOGY
- Tumor PDCD1LG2 (PD-L2) Expression and the Lymphocytic Reaction to Colorectal Cancer
- (2017) Yohei Masugi et al. Cancer Immunology Research
- PD-L2 expression in colorectal cancer: Independent prognostic effect and targetability by deglycosylation
- (2017) Huanbin Wang et al. OncoImmunology
- Genomic Profiling of Small-Bowel Adenocarcinoma
- (2017) Alexa B. Schrock et al. JAMA Oncology
- PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis
- (2017) Lihu Gu et al. PLoS One
- Roles of regulatory T cells in cancer immunity
- (2016) Yoshiko Takeuchi et al. INTERNATIONAL IMMUNOLOGY
- Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial
- (2016) Kei Muro et al. LANCET ONCOLOGY
- Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma
- (2016) Lik Hang Lee et al. MODERN PATHOLOGY
- Prognostic impact of programed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor infiltrating lymphocytes in colorectal cancer
- (2016) Yaqi Li et al. Molecular Cancer
- Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers
- (2016) Takuro Saito et al. NATURE MEDICINE
- PD-L1 is an independent prognostic predictor in gastric cancer of Western patients
- (2016) Christine Böger et al. Oncotarget
- CD8+/FOXP3+ ratio and PD-L1 expression associated with survival in pT3N0M0 stage esophageal squamous cell cancer
- (2016) Yingming Zhu et al. Oncotarget
- The interplay of effector and regulatory T cells in cancer
- (2015) Rahul Roychoudhuri et al. CURRENT OPINION IN IMMUNOLOGY
- Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis
- (2014) Z Mei et al. BRITISH JOURNAL OF CANCER
- Clinical impact of programmed cell death ligand 1 expression in colorectal cancer
- (2013) Raoul A. Droeser et al. EUROPEAN JOURNAL OF CANCER
- B7-H1 Expression Is Associated with Poor Prognosis in Colorectal Carcinoma and Regulates the Proliferation and Invasion of HCT116 Colorectal Cancer Cells
- (2013) Sheng-Jia Shi et al. PLoS One
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intratumoral CD8+ T/FOXP3+ cell ratio is a predictive marker for survival in patients with colorectal cancer
- (2009) Hiroyuki Suzuki et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Small Bowel Cancer in the United States
- (2008) Karl Y. Bilimoria et al. ANNALS OF SURGERY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now